Compound information
- Natural Products
- ZC860174
- Molecular Formula
- C14H16ClN3O5
- Molecular Weight
- 341.077848292 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-(4-chloro-3-nitro-benzoyl)piperazine-1-carboxylate
- InChI
- InChI=1S/C14H16ClN3O5/c1-2-23-14(20)17-7-5-16(6-8-17)13(19)10-3-4-11(15)12(9-10)18(21)22/h3-4,9H,2,5-8H2,1H3
- InChI Key
- NXYQBMHEZLMVFS-UHFFFAOYSA-N
- SMILES
- CCOC(=O)N1CCN(C(=O)c2ccc(Cl)c([N+](=O)[O-])c2)CC1
- Source
- ZINC000000107136
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 92.99 Å2 | LogP | 1.793 |
LogS | -2.907 | LogD | 1.62 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.121 | Pgp substrate | 0.027 |
HIA | 0.976 | F20 % | 0.058 |
F30 % | 0.352 | Caco-2 | -4.375 |
MDCK | -4.62 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.005 | PPB | 82.387 |
VD | 0.972 | Fu | 0.769 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.14 | CYP1A2 substrate | 0.667 |
CYP2A6 substrate | 0.628 | CYP2B6 substrate | 0.716 |
CYP2C19 inhibitor | 0.729 | CYP2C19 substrate | 0.829 |
CYP2C8 substrate | 0.65 | CYP2C9 inhibitor | 0.296 |
CYP2C9 substrate | 0.937 | CYP2D6 inhibitor | 0.269 |
CYP2D6 substrate | 0.536 | CYP2E1 substrate | 0.816 |
CYP3A4 inhibitor | 0.057 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.635 | CL | 1.153 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.119 | Hepatotoxicity | 0.93 |
Mutagenicity | 1.0 | Rat Oral Acute Toxicity | 0.668 |
FDAMDD | 0.153 | Skin Sensitization | 0.941 |
Carcinogenicity | 0.38 | Eye Corrosion | 0.001 |
Eye Irritation | 0.022 | Respiratory Toxicity | 0.013 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.5 | IGC50 | 3.689 |
LC50FM | 2.38 | LC50DM | -1.05 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.614 | NR-AR-LBD | 0.351 |
NR-AhR | 0.515 | NR-Aromatase | 0.027 |
NR-ER | 0.365 | NR-ER-LBD | 0.553 |
NR-PPAR-gamma | 0.116 | SR-ARE | 0.73 |
SR-ATAD5 | 0.493 | SR-HSE | 0.236 |
SR-MMP | 0.006 | SR-p53 | 0.107 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.